Senior insider sale
Chief Financial Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$5.45M
60K shares
What this filing means
BURROWS SCOTT L plans to sell 60K shares of SPYRE THERAPEUTICS, INC. valued at approximately $5.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/3/2026ACC: 0001950047-26-007571
Officer· Chief Financial Officer
Since Mar 2026
60K
Shares to sell
$5.45M
Approx. market value
30K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/3/2026
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/3/2026 | Exercise of Stock Options Cash | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.50K
Market value
$658.0K
7/1/2026
—Completed
Units to sell
15K
Market value
$1.31M
6/25/2026
—Completed
Units to sell
7.50K
Market value
$532.9K
6/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$2.95M
8/3/2026
Total
Units
60K
Value
$5.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 7.50K | $658.0K | — | Completed |
6/25/2026 | 15K | $1.31M | — | Completed |
6/1/2026 | 7.50K | $532.9K | — | Completed |
| Planned — Approximate Date | ||||
8/3/2026 | 30K | $2.95M | NASDAQ | Planned |
| Total | 60K | $5.45M | ||